Advertisement

Chemie der Gestagene

  • K. Junkmann
  • Hedwig Langecker
  • Leonore Damrosch
Part of the Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology book series (HEP, volume 22 / 1)

Zusammenfassung

An dieser Stelle soll die Chemie der in diesem Band besprochenen Stoffe nur soweit behandelt werden, als es zum Verständnis der Nomenklatur und zur grobchemisehen Charakterisierung und Identifizierung der wesentlichsten Gestagene erforderlieh ist. Fast alle Gestagene gehören zur Klasse der Steroide, die 1936 [30] aus Sterinen, Gallensäuren, Steroid-Sapogeninen, Steroidalkaloiden, den Herzglykosiden und den Steroidhormonen gebildet wurde.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. [1]
    Allen, E., and E. A. Doisy: An ovarian hormone. Preliminary report on its localization. extraction and partial purification and action in test animals. J. Amer. med. Ass 81, 819 (1923).Google Scholar
  2. [2]
    Allen jr., G. R., and N. A. Austin: Halogenated progesterones. A preferential reaction of perchloryl fluoride. J. organ. Chem. 26, 5245 (1961).Google Scholar
  3. [3]
    Allen, W. M.: Physiology of the corpus luteum. V. The preparation and some clinical properties of progestin, a hormone of the corpus luteum, which produces progestational proliferation. Amer. J. Physiol. 92, 174 (1930).Google Scholar
  4. [4]
    Allen, W. M. and G. W. Corner: Physiology of corpus luteum. VII. Maintenance of pregnancy in rabbit after very early castration, by corpus luteum extracts. Proc. Soc. exp. Biol. (N.Y.) 27, 403 (1930).Google Scholar
  5. [5]
    Allen, W. M, G. W. Corner and M. Ehrenstein: 10-Norprogesterone, a physiologically active lower homolog of progesterone. Science 100, 251 (1944).PubMedGoogle Scholar
  6. [6]
    Allen, W. M, G. W. Corner, M. Ehrenstein and O. Wintersteiner: Crystalline progestin. Science 80, 190 (1934).PubMedGoogle Scholar
  7. [7]
    Allen, W. S., and S. Bernstein: 16-Hydroxylated steroids. The preparation of 16 α- hydroxyhydrocortisone and related compounds. J. Amer. chem. Soc. 78, 1909 (1956).Google Scholar
  8. [8]
    Allen, W. S.,S. Bernstein, and R. Littel: Steroidal cyclic ketals. The conversion of 11-epi-hydrocortisone into hydrocortisone. J. Amer. chem. Soc. 76, 6116 (1954).Google Scholar
  9. [9]
    Aydar, C. K., and R. B. Greenblatt: Clinical observations on a new progestational agent, “allylestrenol”. Acta endocr. (Kbh.) 38, 419 (1961)Google Scholar
  10. [10]
    Babcock, J. C., E. S. Gutsell, M. E. Herr, J. A. Hogg, J. C. Stucke, L. E. Barnes, and W. E. Dflin: 6α-Methyl-17α-hydroxyprogesterone-17-acylates; a new class of potent progestins. J. Amer. chem. Soc. 80, 2904 (1958).Google Scholar
  11. [11]
    Barber, G. W., u. M. Ehrenstein: Synthese von 19-Nor-10 ζ, 14 β, 17α-progesteron und 19-Nor-11 -desoxy-10 ζ, 14β,17 α-corticosteron aus Strophantidin. Justus Liebigs Ann. Chem. 603, 89 (1957).Google Scholar
  12. [12]
    Barton, S. P., D. Burn, G. Cooley, B. Ellis, and V. Petrow: Modified steroid hor mones. Part XI. Some ethisterone homologues. J. chem. Soc. 1959, 1957.Google Scholar
  13. [13]
    Barton, S. P. B. Ellis, and V. Petrow: Preparation of 17α-acetoxy-6α-methylprogesterone. J. chem. Soc. 1959, 478.Google Scholar
  14. [14]
    Bharucha, K. R., G. C. Buckley, C. K. Cross, J. L. Rubin, and P. Ziegler: The conversion of hyo-desoxy-cholic acid into progesteron. Canad. J. Chem. 34, 982 (1956).Google Scholar
  15. [15]
    Berthold, A. P.: Transplantation der Hoden. Arch. Anat. Physiol, wiss. Med. 1849, 42.Google Scholar
  16. [16]
    Biedl, A.: Innere Sekretion, Bd. 2. Berlin u. Wien: Urban & Schwarzenberg 1913.Google Scholar
  17. [17]
    Butenandt, A.: Über „Progynon“, ein kristallisiertes weibliches Sexualhormon. Natur wissenschaften 17, 879 (1929).Google Scholar
  18. [18]
    Butenandt, A. Über das Pregnandiol, einen neuen Sterin-Abkömmling aus Sehwangerenharn. Ber. dtsch. chem. Ges. 63, 659 (1930).Google Scholar
  19. [19]
    Butenandt, A. Über das Pregnandiol, einen neuen Sterin-Abkömmling aus Sehwangerenharn. II. Mitt. Ber. dtsch. chem. Ges. 64, 2529 (1931).Google Scholar
  20. [20]
    Butenandt, A. Über die Chemie der Sexualhormone. Angew. Chem. 45, 655 (1932).Google Scholar
  21. [21]
    Butenandt, A. Chemical constitution of the follicular and testicular hormones. Nature (Lond.) 130, 238 (1932).Google Scholar
  22. [22]
    Butenandt, A., u. J. Schmidt: Überführung des Pregnandiols in corpusluteum-Hormon. Ber. dtsch. chem. Ges. 67, 1901 (1934).Google Scholar
  23. [23]
    Butenandt, A., u. J. Schmidt-Thomé: Überführung von Dehydroandrosteron in Progesteron etc. Ber. dtsch. chem. Ges. 72, 182 (1939).Google Scholar
  24. [24]
    Butenandt, A., u. G. Schramm: Steroide. In: A. Flaschenträger u. E. Lehnartz, Physiologische Chemie, Bd. 1, S. 431—436. Berlin-Göttingen-Heidelberg: Springer 1951.Google Scholar
  25. [25]
    Butenandt, A., u. U. Westphal: Über die Darstellung des Corpus luteum-Hormons aus Stigmasterin; die Konstitution des Corpus luteum-Hormons. Ber. dtsch. chem. Ges. 67, 2085 (1934).Google Scholar
  26. [26]
    Butenandt, A. U. Westphal, u. H. Cobler: Über einen Abbau des Stigmasterin zu corpus-luteum-wirksamen Stoffen; ein Beitrag zur Konstitution des Corpus luteum-Hormons. Ber. dtsch. chem. Ges. 67, 1611 (1934).Google Scholar
  27. [27]
    Butenandt, A., U. Westphal, u. W. Hohlweg: Über das Hormon des Corpus luteum. Hoppe-Seylers Z. physiol. Chem. 227, 84 (1934).Google Scholar
  28. [28]
    Cattn, R. S., C. K. Ingold, and Y. Prelog: The specification of asymmetric configuration in organic chemistry. Experientia (Basel) 12, 81 (1956).Google Scholar
  29. [29]
    Cattn, R. S. C. Ingold u. V. Prelog: Spezifikation der molekularen Chiralität. Angew. Chem. 78, 401 (1966).Google Scholar
  30. [30]
    Callow, R. K., and F. G. Young: Relations between optical rotatory power and constitution in the steroids. Proc. roy. Soc. Med. 157A, 194 (1936).Google Scholar
  31. [31]
    Chevreul, M. E.: Ann. Chim. [1], 95, 7, 48 (1815). Zit. nach P. Jacobson, Lehrbuch der organischen Chemie, Bd. 2, Teil 4, S. 181. Berlin u. Leipzig: W. de Gruyter & Co. 1924.Google Scholar
  32. [32]
    Chevreul, M. E. Recherehes chimiques sur les corps gras d’origine animale. IX. De la Cholesterine, p. 155–159. Paris et Strassburg: F. G. Levrault 1823.Google Scholar
  33. [33]
    Clauberg, C.: Experimentelle Untersuchungen zur Frage eines Mäusetestes für das Hormon des Corpus luteum. Klin. Wschr. 9, 2004 (1930).Google Scholar
  34. [34]
    Clauberg, C. Der biologische Test für dsa Corpus luteum-Hormon. Zbl. Gynäk. 54, 1154 (1930).Google Scholar
  35. [35]
    Clauberg, C. Zur Physiologie und Pathologie der Sexualhormone, im besonderen des Hormons des Corpus luteum. I. Mitt. Der biologische Test für das Luteohormon am infantilen Kaninchen. Zbl. Gynäk. 54, 2757 (1930).Google Scholar
  36. [36]
    Colton, F. B.: Estradienes. Chem. Abstr. 49, 11729 (1955).Google Scholar
  37. [37]
    Colton, F. B. 17-Alkyl-derivates of 19-nortestosterone. Chem. Abstr. 50, 7890e (1956).Google Scholar
  38. [38]
    Colton, F. B. 4-Östren-3, 17diole and their esters. Chem. Abstr. 53, 1415 (1959).Google Scholar
  39. [39]
    Colton, F. B., and N. W. Atwater: 6α, 17α Dialkyl-17-hydroxy-19-nor-4-androsten-3-ones. Chem. Abstr. 54, 1623 (1960).Google Scholar
  40. [40]
    Colton, F. B. L. N. Nysted, B. Riegel, and A.L. Raymond: 17-Alkyl-19-nortestosterones. J. Amer. chem. Soc. 79, 1123 (1957).Google Scholar
  41. [41]
    Corner, G. W.: The hormones of human reproduction. Princeton, N.J.: Princeton University Press 1942.Google Scholar
  42. [42]
    Corner, G. W., and W.M. Allen: Physiology of the corpus luteum. II. Production of a special uterine reaction (progestational proliferation) by extracts of the corpus luteum. Amer. J. Physiol. 88, 326 (1929).Google Scholar
  43. [43]
    David, A., F. Hartley, D. R. Millson, and V. Petrow: The preparation and progestational activity of some alkylated ethisterones. J. Pharm. Pharmacol. 9, 929 (1957).PubMedGoogle Scholar
  44. [44]
    Deghendhi, R., and C. Revesz: The oral activity of 17α-substituted pregnenolones and their sulphates. J. Endocr. 81, 301 (1965).Google Scholar
  45. [45]
    Deghendhi, R. C. Revesz and R. Gaudry: New synthesis and structure activity relationship in the 17-alky-lated progesterone series. J. med. Chem. 6, 301 (1963).Google Scholar
  46. [46]
    Djerassi, C., L. Miramontes, G. Rosenkranz, and F. Sondheimer: Steroids. LIV. J. Amer. chem. Soc. 76, 4092 (1954).Google Scholar
  47. [47]
    Doisy, E. A., C. D. Veler, and S. A. Thayer: Folliculin from urin of pregnant women. Amer. J. Physiol. 90, 329 (1929).Google Scholar
  48. [48]
    Drill, V. A.: Endocrine properties of norethynodrel and related steroids. Proc. roy. Soc. Med. 55, 1002 (1962).Google Scholar
  49. [49]
    Drill, V. A. and B. Riegel: Structural and hormonal activity of some new steroids. Recent Progr. Hormone Res. 14, 29 (1958).PubMedGoogle Scholar
  50. [50]
    Dusza, J. P., J. P. Joseph, and S. Bernstein: C6 Hydroxylated steroids. 6-Hydroxy-lated 17 α acetoxyprogerone, 17 α aeetoxy-6-methylprogesterone and related compounds. J. organ. Chem. 28, 92 (1963).Google Scholar
  51. [50a]
    Edgren, R. A., R. C. Jones, De Ann L. Peterson, and A. L. Gillen: Studies on the interactions of ethynyl oestradiol and norgestrel. Acta endocr. (Kbh.), Suppl. 115, 1 (1967).Google Scholar
  52. [50b]
    Edgren, R. A. H. Smith, G.A. Hughes, L. L. Smith, and G. Greenspan: Biological effects of racemic and resolved 13β-ethyl-4-gonen-3-ones. Steroids 2, 731 (1963).Google Scholar
  53. [50c]
    Edgren, R. A. H. Smith De Ann L. Petersen, and D. L. Carter: The biological effects of a series of 13β-substituted gonanes related to norethisterone (17α-ethynyl-19-nortestosterone). Steroids 2, 319 (1963).Google Scholar
  54. [51]
    Editorial: Specific steroid. Chem. Eng. News 35, 30 (1957).Google Scholar
  55. [52]
    Ehrenstein, M.: Steroids. VIII. Lower homologs of hormones of the pregnane series:10-nor-11-desoxyeorticosterone acetate and 10-nor-progesterone. J. organ. Chem. 9, 435 (1944).Google Scholar
  56. [53]
    Elton, R. L., and E. F. Nutting: 17-Ethynyl-4-estrene-3–17-diol diacetate: A unique steroidal “progestin“. Proc. Soc. exp. Biol. (N.Y.) 107, 991 (1961).Google Scholar
  57. [54]
    Engel, Ch. R., and R. Deghenghe: The synthesis of 6α-fluoro-17α-bromprogesterone. Cand. J. Chem. 38, 452 (1960)Google Scholar
  58. [55]
    Ercoli, A.: Éthers en série stéroide. Bull. Soe. chim. Fr. 11, 3099 (1965).Google Scholar
  59. [56]
    Ercoli, A. G. Bruni, G. Falconi, F. Galetti, and R. Gardi: Biological effectiveness of enol ethers of Δ 4-3-keto steroidal hormones and their paradoxical dependency on administration route. Acta endocr. (Kbh.), Suppl. 51, 857 (1960).Google Scholar
  60. [57]
    Ercoli, A., and A. R. Gardi: Δ 4-3-Ketosteroidenolether. Paradoxical dependency of their effectiveness on administration route. J. Amer. ehem. Soc. 82, 746 (1960).Google Scholar
  61. [58]
    Ercoli, A. R. Gardi, and G. Bruni: Ether derivatives of steroid hormones. Res. Progr. organ. Biol. med. Chem. I, 156 (1964).Google Scholar
  62. [59]
    Falconi, G., u. A. Ercoli: Reduzierte akute Toxizität der Enoläther im Vergleich zu den korrespondierenden Steroidhormonen. Boll. Soc. ital. Biol. sper. 87, 1436 (1961).Google Scholar
  63. [60]
    Ferin, J.: A new substance with progestational activity. Comparative assays in ovariectomized women clinical results. Acta endocr. (Kbh.) 22, 303 (1956).Google Scholar
  64. [61]
    Ferin, J. Découverte d’un stéroide progestogène très actif chez la femme. Ann. Endocr. (Paris) 17, 261 (1956).Google Scholar
  65. [62]
    Fernholz, E.: Zur Synthese des Corpus luteum-Hormons. (Vorläufige Mitt.). Ber. dtsch. chem. Ges. 67, 1855 (1934).Google Scholar
  66. [63]
    Fernholz, E. Die Darstellung des Corpus luteum-Hormons aus Stigmasterin. Ber. dtsch. chem. Ges. 67, 2027 (1934).Google Scholar
  67. [64]
    Fieser, L. F., and M. Fieser: Steroids, Waverly Press Inc. 1959 — deutsch: Steroide. Weinheim/Bergstr.: Verlag Chemie 1961.Google Scholar
  68. [65]
    Fraenkel, L.: Versuche über den Einfluß der Ovarien auf die Insertion des Eies. Verh. dtsch. Ges. Gynäk. 1901, 571.Google Scholar
  69. [66]
    Fraenkel, L. Zur Funktion des Corpus luteum. Arch. Gynäk. 68, 438 (1902).Google Scholar
  70. [67]
    Fraenkel, L. Weitere Mitteilungen über die Funktion des Corpus luteum. Zbl. Gynäk. 1904, 28.Google Scholar
  71. [68]
    Fraenkel, L. Über innere Sekretion des Ovarium. Z. Geburtsh. Gynäk. 64, 426 (1909).Google Scholar
  72. Fraenkel, L. Neue Experimente zur Funktion des Corpus luteum. Arch. Gynäk. 91, 705 (1910).Google Scholar
  73. [70]
    Fraenkel, L., u. F. Cohn: Experimentelle Untersuchungen über den Einfluß des Corpus luteum auf die Inersertion des Eies. Anat. Anz. 20, 294 (1901).Google Scholar
  74. [71]
    Fried, J., J.E. Herz, E. F. Sabo, A. Borman, F.M. Singer, and P. Numerof: 9α-Halo-11β-hydroxy and 11-keto derivatires of progesterone, desoxycortieosterone and 17α-hydroxyprogesterone. J. Amer. chem. Soc. 77, 1068 (1955).Google Scholar
  75. [72]
    Fried, J. E. F. Sabo, P. Grabowich, L. J. Lerner, W. B. Kessler, D. M. Breman, and A. Borman: Progestationally activ acetals and ketals of 16α,17α-dihydroxypro- gesterone. Chem. Ind. 1961, 465.Google Scholar
  76. [73]
    Giral, F.: 20-Monoxim of progesterone. Ciencia (Méx.) 14, 210 (1954).Google Scholar
  77. [74]
    Girard, A., et G. Sandulesco: Sur une nouvelle série des réactifs du group carbonyle, leur utilisation à l’extraction des substances cétoniques et à la charactérisation microchimique des aldéhydes et cétones. Helv. chim. Acta 19, 1095 (1936).Google Scholar
  78. [75]
    Gleason, C. H., and G. W. Holden: Androstenedione and progesterone. Chem. Abstr. 52, 2948 (1958).Google Scholar
  79. [76]
    Hartmann, M., u. A. Wettstein: Ein kristallisiertes Hormon aus Corpus luteum. Helv. chim. Acta 17, 878 (1934).Google Scholar
  80. [77]
    Hench, P. S., E. C. Kendall, C. H. Slocumb, and H. F. Polley: Effect of a hormone of adrenal cortex (17-hydroxy-ll-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc. Mayo Clin. 24, 181 (1949).Google Scholar
  81. [78]
    Hertz, R., W. Tullner, and E. Raffelt: Progestational activity of orally administered 17α-ethinyl-19-nortestosterone. Endocronology 54, 228 (1954).Google Scholar
  82. [79]
    Hogg, J. A., G. B. Spero, J. L. Thompson, B. J. Magerlein, W. P. Schneider, D. H. Peterson, O. K. Sebeck, H. C. Murray, J. C. Babcock, R. L. Pederson, and C. A. Campbell: 6-Fluoro analogues of steroid hormones. Chem. Ind. 32, 1002 (1958).Google Scholar
  83. [80]
    Hohlweg, W.: Die Hormone der Keimdrüsen in Biologie und Pathologie des Weibes. In: Handbuch der Frauenheilkunde und Geburtshilfe (L. Seitz u. A. I. Amreich), 2. Aufl., Bd. 1/1, S. 525. Berlin-Innsbruck-München-Wien: Urban & Schwarzenberg 1953.Google Scholar
  84. [81]
    Howard, G. A., H. J. Ringold, and E. Batres: 6-Chloro-4,6-pregnadien-17α-ol-3,20-dion-17-acetate. Chem. Abstr. 58, 10281 (1963).Google Scholar
  85. [82]
    Huang-Minlon, K. Tien Han, and Wei-Stran Chou: Synthesis of Δ 6 6-methyl steroids. Chem. Abstr. 59, 12868 (1963).Google Scholar
  86. [83]
    Huang-Minlon, K. E. Wilson, N. L. Wendler, and M. Tishler: Steroid-17 α-acetats. J. Amer. chem. Soc. 74, 5394 (1952).Google Scholar
  87. [84]
    Hüttenrauch, R.: Darstellung geminaler chlor-nitroso-Verbindungen der Steroide. Arch. Pharm. (Weinheim) 294, 366 (1961).Google Scholar
  88. [85]
    Inhoffen, H. H., u. W. Hohlweg: Neue per os wirksame weibliche Keimdrüsenhormon- Derivate: 17-Äthinyloestradiol und Pregnenin-on-3-ol-17. Naturwissenschaften 26, 96 (1938).Google Scholar
  89. [86]
    Inhoffen, H. H., W. Logemann, W. Hohlweg u. A. Serini: Untersuchungen in der Sexualhormon-Reihe. Ber. dtsch. chem. Ges. 71, 1024 (1938).Google Scholar
  90. [87]
    Iriarte, J., C. Djerassi, and H. J. Ringold: Δ 5(6)-19-Nor steroids, a new class of potent anabolic agents. J. Amer. chem. Soc. 81, 436 (1959).Google Scholar
  91. [88]
    Junkmann, K.: Über protrahiert wirksame Gestagene. Naunyn-Schmiedebergs Arch, exp. Path. Pharmak. 228, 244 (1954).Google Scholar
  92. [89]
    Junkmann, K. Long-Acting steroids in reproduction. Recent Progr. Hormone Res. 13, 389 (1957).PubMedGoogle Scholar
  93. [90]
    Junkmann, K. Über Entwicklungen auf dem Gestagengebiet. Med. Japan, Proc. Fifteenth Gen. Ass. Japan Med. Congr. 1, 697 (1959).Google Scholar
  94. [91]
    Kamp, H. van, P. Westerhof, and H. Niewind: Synthesis of 9β, 10 α-progesterone-4-t and 4-t 6-dehydro 9β,10α-progesterone. Chem. Abstr. 61, 4422 (1964).Google Scholar
  95. [92]
    Kamp, H. P.Westerhof, and H. Niewind: The synthesis of 4-H3-9β,10α-progesterone and 4-H3-6-dehydro-9β,10α-progesterone. Ree. Trav. chim. Pays-Bas 83, 509 (1964).Google Scholar
  96. [93]
    Kassenaar, A., A. Querido, and H. F. L. Schöler: Pharmacological properties of retrotestosterone derivatives. Acta endocr. (Kbh.), Suppl. 51, 859 (1960).Google Scholar
  97. [94]
    Kathol, J., W. Logemann u. A. Serini: Ein Übergang aus der Androstan-Reihe in die Pregnan-Reihe. Naturwissenschaften 25, 682 (1937).Google Scholar
  98. [95]
    Kaufmann, C.: Umwandlung der Uterasschleimhaut einer kastrierten Frau aus dem atrophischen Stadium in das der sekretorischen Funktion durch Ovarialhormone. Zbl. Gynäk. 56, 2058 (1932).Google Scholar
  99. [96]
    Kaufmann, C. Verhandlungen der Gesellschaft für Geburtshilfe und Gynäkologie zu Berlin. Geburtsh. u. Frauneheilk. 104, 516 (1933).Google Scholar
  100. [97]
    Kaufmann, C. Echte menstruelle Blutung bei kastrierten Frauen nach Zufuhr von Follikel- und Corpus luteum-Hormon. Klin. Wsehr. 12, 217 (1933).Google Scholar
  101. [98]
    Kincl, F. A.: Progestative Wirksamkeit von 6-substituierten 17α-Acetoxyprogesteron-Derivaten. Endokrinologie 40, 257 (1961).PubMedGoogle Scholar
  102. [99]
    Kincl, F. A., and R. I. Dorfman: Orally active steroidal ovulation inhibitors in the adult estrus rabbit. Steroids 2, 521 (1963).Google Scholar
  103. [100]
    Lefebore, Y. von, et R. Gaudry: La réaction du pentachlorure de phosphore sur les acyloxy-3β-Δ 4 ceto-6-steroides. Canad. J. Chem. 43, 1990 (1965).Google Scholar
  104. [101]
    Loeb, L.: Über die experimentelle Erzeugung von Knoten von Deciduagewebe im Uterus des Meerschweinchens nach stattgefundener Kopulation. Zbl. allg. Path, path. Anat. 18, 563 (1907).Google Scholar
  105. [102]
    Loeb, L. Über die künstliche Erzeugung der Decidua und über die Bedeutung der Ovarien für die Deeiduabildung. Zbl. Physiol. 22, 498 (1908).Google Scholar
  106. [103]
    Loeb, L. The experimental production of the maternal placenta. J. Amer. med. Ass. 53, 1471 (1909).Google Scholar
  107. [104]
    Loeb, L. Über die Bedeutung des Corpus luteum. Zbl. Physiol. 23, 73 (1909).Google Scholar
  108. [105]
    Loeb, L. The function of corpus luteum, the experimental production of the maternal placenta and the mechanism of the sexual cycle in the female organism. Med. Ree. (N.Y.) 77, 1083 (1910).Google Scholar
  109. [106]
    Loeb, L. The experimental production of the maternal placenta. Proc. path. Soc. Philad. 1910, 94.Google Scholar
  110. [107]
    Loeb, L. The reaction of the uterine mucosa towards foreign bodies introduced into the uterine cavity. Proc. Soc. exp. Biol. (N.Y.) 7, 90 (1910).Google Scholar
  111. [108]
    Loeb, L. Über die Bedeutung des Corpus luteum für die Periodizität des sexuellen Zyklus beim weiblichen Säugetierorganismus. Dtseh. med. Wschr. 1, 17 (1911).Google Scholar
  112. [109]
    Madjerek, Z., J. de Visser, J. van der Vies, and G. A. Overbeek: Allylestrenol, a pregnancy-maintaining oral gestagen. Acta endocr. (Kbh.) 35, 8 (1960).Google Scholar
  113. [110]
    Marker, R. E., and E. Rohrmann: Sterols. LXXXI. Conversion of sarsasapogenin to Pregnanediol-(3α,20α) J. Amer. chem. Soc. 61, 3592 (1939).Google Scholar
  114. [111]
    Marker, R. E. T. Tsukamoto, and D. L. Turner: Sterols. C. Biosgenin. J. Amer. chem. Soc. 62, 2525 (1940).Google Scholar
  115. [112]
    Marker, R. E. R. B. Wagner, P. R. Ulshafer, E. L. Wittbecker, D. P. J. Goldsmith, and C. H. Ruof: Steroidal sapogenins. J. Amer. chem. Soc. 69, 2167 (1947).Google Scholar
  116. [113]
    Marrian, G. F.: The chemistry of oestrin. Preparation from urine and separation from an unidentified solid alcohol. Biochem. J. 23, 1090 (1929).PubMedGoogle Scholar
  117. [114]
    Marshall, D. J., and R. Gaudry: 17α-Halogenated progesterones: Orally-active progestins. Canad. J. Chem. 38, 1495 (1960).Google Scholar
  118. [115]
    Marshall, C. W., R. E. Ray, I. Laos, and B. Riegel: 7-Keto steroids. Steroidal 3-hydroxy-3,5-dien-7-ones. J. Amer. chem. Soc. 79, 6303 (1957).Google Scholar
  119. [116]
    Mauthner, J., u. W. Sueda: Beiträge zur Kenntnis des Cholesterins. Mh. Chem. 15, 85 (1894).Google Scholar
  120. [117]
    Mauthner, J., u. W. Suida: Beiträge zur Kenntnis des Cholesterins. Über die Oxydation von Cholesterin und seinen Abkömmlingen. Mh. Chem. 17, 579 (1896).Google Scholar
  121. [118]
    McGinty, D. A., and C. Djerassi: Some chemical and biological properties of 19-nor-17α-ethinyltestosterone. Ann. N.Y. Acad. Sei. 71, 500 (1958).Google Scholar
  122. [119]
    McPttatti, M. K.: The assay of progestin. J. Physiol. (Lond.) 83, 145 (1934).Google Scholar
  123. [120]
    Meystre, Ch., H. Frey, E. Neher, A. Wettstein u. K. Miescher: Ein einfacher Abbau der Gallensäuren-Seitenkette, ie Überführung von Δ 5-3β-Oxy-cholensäure in Pregnenolon und Progesteron. Helv. chim. Acta 29, 627 (1946).Google Scholar
  124. [121]
    Meystre, Ch. E. Tschopp u. A. Wettstein: Über Steroide. 81. Mitt. Über 11-Dehydro-progesteron, das wirksamste Gestagen. Helv. chim. Acta 31, 1463 (1948).PubMedGoogle Scholar
  125. [122]
    Miescher, K.: On the relation of activity to constitution in the sexogens, with special reference to the doisynolic acids. Recent Progr. Hormone Res. 3, 47 (1948).Google Scholar
  126. [123]
    Mills, J. S., O. Candiani, and C. Djerassi: Synthesis of some 6α,17α-dihalopro-gesterones. J. organ. Chem. 25, 1056 (1960).Google Scholar
  127. [124]
    Miramontes, L., G. Rosenkranz, and C. Djerass: The synthesis of 19-nor-progesterone. J. Amer. chem. Soc. 73, 3540 (1951).Google Scholar
  128. [125]
    Miramontes, L. G. Rosenkranz, C. Djerassi, and F. Sondheimer: 19-Nor-deoxycorticosterone, a potent mineralcorticoid hormon. J. Amer. chem. Soc. 75, 4117 (1953).Google Scholar
  129. [126]
    Neudert, W., u. H. Röpke: Steroid Spektrenatlas. Berlin-Heidelberg-New York: Springer 1965.Google Scholar
  130. [127]
    Neumann, F., M. Kramer u. K. Junkmann: Tierexperimentelle Untersuchungen mit 17α-Äthinyl-19-nor-testosteronacetat. Med. exp. (Basel) 11, Suppl. 1 (1964).Google Scholar
  131. [128]
    Noall, M. W., H. A. Salhanick, G. M. Neher, and M. X. Zarrow: Method for the isolation of progesterone from human placentae. J. biol. Chem. 201, 321 (1953).PubMedGoogle Scholar
  132. [129]
    Organon Laboratories Ltd.: 19-Norsteroid-eompounds. Chem. Abstr. 55, 9475 (1961).Google Scholar
  133. [130]
    Overbeek, G. A., and A. Z. Madjerek: The effects of steroids on deeiduoma-formation in mice. Bull. Soc. roy. belge Gynée. Obstét. 30, 555 (1960).Google Scholar
  134. [131]
    Overbeek, G. A.. et J. de Visser: Recherches pharmacologiques avec la méthyloestrénolone. Ann. Endoer. (Paris) 17, 268 (1956).Google Scholar
  135. [132]
    Overbeek, G. A. J. de Visser A new substance with progestational activity. II. Pharmacological properties. Acta endocr. (KbH.) 22, 318 (1956).Google Scholar
  136. [133]
    Parkes, A. S.: The rise of reproductive endocrinology, 1926—1940. The Sir Henry Dale lecture for 1965. J. Endocr. 34, XX (1966).Google Scholar
  137. [134]
    Pearlman, W. H., and E. Cerceo: The estimation and α, β-unsaturated ketonic compounds in placental extracts. J. biol. Chem. 203, 127 (1953).PubMedGoogle Scholar
  138. [135]
    Pincus, G., M. C. Chang, M. X. Zarrow, and A. Merrill: Studies of the biological activity of certain 19-nor steroids in female animals. Endocrinology 59, 694 (1956).Google Scholar
  139. [136]
    Prenant, A.: De la valeur morphologique du corps jaune, son action physiologique et thérapeutique possible. Révue gén. Sei. 1898. Zitiert nach [16], p. 297.Google Scholar
  140. [137]
    Rappoldt, M.P., and P. Westerhof: 6-Dehydro-9β, 10α-progesterone from pregnenolone. Chem. Abstr. 55, 16597 (1961).Google Scholar
  141. [138]
    Rappoldt, M.P., and P. Westerhof: 6 -Dehydro-9β,10α-progesterone from pregnenolone. Ree. Trav. chim. Pays-Bas 80, 43 (1961).Google Scholar
  142. [139]
    Reerink, E. H., H. F. L. Schöler, P. Westerhof, A. Querido, A. A. H. Kassenaar, E. Diczfalusy, and K. C. Tillinger: A new class of hormonal active steroids. Nature (Lond.) 186, 168 (1960).Google Scholar
  143. [140]
    Reich, H., K. F. Crane, and S. J. Sanfilippo: The reaction of steroid ketones with 2,4-dinitro-phenylhydrazine. J. organ. Chem. 18, 822 (1953).Google Scholar
  144. [141]
    Ringold, H. J., G. Rosenkranz, and F. Sondheimer: Steroids. LXXX. 1-Methyl-19-nortestosterone and l-methyl-17α-ethinyl-19-nortestosterone. J. Amer. chem. Soc. 78, 2477 (1956).Google Scholar
  145. [142]
    Ringold, H. J. J. P. Ruelas, E. Batres, and C. Djerassi: Steroids. CXVIII. 6-Methyl. Derivatives of 17α-hydroxyprogesterone and of Reichstein’s Substance “S”. J. Amer, chem. Soc. 81, 3712 (1959).Google Scholar
  146. [143]
    Ringold, H. J. J. P. Ruelas E. Batres C. Djerassi 6-Methyl derivatives of 17α-hydroxyprogesterone and of Reichstein’s Substance “S”. J. Amer. chem. Soc. 81, 3714 (1959).Google Scholar
  147. [144]
    Ringold, H. J. E. Batres, A. Bowers, J. Edwards, and J. Zderic: Steroids. CXXVÏI. 6-Halo progestational agents. J. Amer. chem. Soc. 81, 3485 (1959).Google Scholar
  148. [145]
    Sandoval, A., G. J. Thomas, C. Djerassi, G. Rosenkranz, and F. Sondheimer: Steroids. LXI. Synthesis of 19-nor-desoxycorticosterone, a potent mineralocorticoid hormone. J. Amer. chem. Soc. 77, 148 (1955).Google Scholar
  149. [146]
    Saunders, F. J., F. B. Colton, and V. A. Drill: Progesterone-like activity of a series of 19-nor-testosterones. Proc. Soc. exp. Biol. (N.Y.) 94, 717 (1957).Google Scholar
  150. [147]
    Saunders, F. J. R. A. Edgren, and V. A. Drill: On the progesteron activity of 17α-ethinyl- 17-hydroxy-Δ 5(10)-estren-3-on (Norethinodrel). Endocrinology 60, 804 (1957).PubMedGoogle Scholar
  151. [148]
    Schöler, H.F.L., E.H. Reerink, and P. Westerhof: Pharmacological properties of some 9β, 10α-steroid hormones (retro-steroids). Acta endocr. (Kbh.), Suppl. 51, 917 (1960).Google Scholar
  152. [149]
    Schöler, H.F.L.. E. H. Reerink, P. Westerhof: The progestational effect of a new series of steroids. Acta physiol. pharmacol. neerl. 9, 134 (1960).PubMedGoogle Scholar
  153. [150]
    Slotta, K. H., H. Ruschig u. E. Fels: Reindarstellung der Hormone aus dem Corpus luteum. Ber. dtsch. chem. Ges. 67, 1270 (1934).Google Scholar
  154. [151]
    Smit, A., and P. Westerhof: An alte. iative route for the synthesis of some 6-dehydro-9β,10α-steroid hormone analogues. Ree. Trav. chim. Pays-Bas 82, 1107 (1963).Google Scholar
  155. [151a]
    Smith, H., G.A. Hughes, and G.H. Douglas: Totally synthetic (±)-13-alkyl- 3-hyd oxy and methoxygona-1,3,5 (10)-trien-17-ones and related compounds. Experientia (Basel) 19, 394 (1963).Google Scholar
  156. [152]
    Sondheimer, F., and Y. Klibansky: Synthesis of 3-hydroxy analogues of steroidal hormones, a biologically active class of compounds. Tetrahedron 5, 15 (1959).Google Scholar
  157. [153]
    Sondheimer, F. M. Valasco, and G. Rosenkranz: Synthesis of progesterone 3-eyeloethylen ketal. J. Amer. chem. Soc. 77 192 (1955).Google Scholar
  158. [154]
    Szpilfogel, S. A.: Herst ilung von biologisch aktiven Steroidverbindungen. Chem. Zbl. 130, 11352 (1959).Google Scholar
  159. [155]
    Tsukamoto, T., u. Y. Ueno: Untersuchung der Glykoside von Dioscorea Tokoro Makino. J. pharm. Soc. Japan 56, 135 (1936).Google Scholar
  160. [156]
    Turner, R. B.: Acylation of 17 α-oxy-20-ketosteroids: Compound L. J. Amer. chem. Soc. 74, 4220 (1952).Google Scholar
  161. [157]
    Turner, R. B. Acylation of 17-oxy-20-ketosteroids. J. Amer. chem. Soc. 75, 3489 (1953).Google Scholar
  162. [158]
    Ueberwasser, H., K. Heusler, J. Kalvoda, Ch. Meystre, P. Wieland, G. Anner u. A. Wettstein: Ein einfaches Herstellungsverfahren für 19-Norandrostan- Derivate. Helv. chim. Acta 46, 344 (1963).Google Scholar
  163. [159]
    Vischer, E., Ch. Meystre u. A. Wettstein: Mikrobiologische Herstellung von 1-De-hydro-Steroiden. Helv. chim. Acta 38, 835 (1955).Google Scholar
  164. [160]
    Wada, S.: Derivatives of steroidal hormones. Progesterone 3-enolbenzoate and 3-mono-semicarbazone. Chem. Abstr. 50, 5006 (1956).Google Scholar
  165. [161]
    Westerhof, P., and E. H. Reerink: Synthesis and properties of 9β, 10α-progesterone and 6-dehydro-9β, 10α-progesterone. Chem. Abstr. 55, 1701 (1961).Google Scholar
  166. [162]
    Wied, G. L., and M.E. Davis: Some biological activities of certain progestogens: 9- and 12-halo-11-oxygenated progesterones. Ann. N.Y. Acad. Sei. 71, 494 (1958).Google Scholar
  167. [163]
    Wied, G. L. M.E. Davis 9α-Brom-11-ketoprogesterone. Another new orally effective substance with progestational activity. Biol. Abstr. 32, 12210 (1958).Google Scholar
  168. [164]
    Wiley, R. H., and S. H. Chang: Steroid dimethylhydrazones. J. med. Chem. 6, 610 (1963).PubMedGoogle Scholar
  169. [165]
    Winter, de M.S., C. M. Siegmann, and S. A. Szpilfogel: 17-Alkylated 3-deoxo-19-nortestosterones. Chem. and Ind. 1959, 905.Google Scholar
  170. [166]
    Wintersteiner, O., and W. M. Allen: Crystalline progestin. J. biol. Chem. 107, 321 (1934).Google Scholar
  171. [167]
    Zderic, J. A., D. C. Limon, H. J. Ringold, and C. Djerassi: Cycloethylene ketal formation of 19-nor-Δ 4-3-keto steroids. J. Amer. chem. Soc. 81, 3120 (1959).Google Scholar

Copyright information

© Springer-Verlag / Berlin · Heidelberg 1968

Authors and Affiliations

  • K. Junkmann
  • Hedwig Langecker
  • Leonore Damrosch

There are no affiliations available

Personalised recommendations